{"title":"Nitric oxide protects intestinal mucosal barrier function and prevents acute graft rejection after intestinal transplantation: A mini-review","authors":"George J. Dugbartey , Deborah Nanteer , Ivy Osae","doi":"10.1016/j.niox.2024.05.001","DOIUrl":"10.1016/j.niox.2024.05.001","url":null,"abstract":"<div><p>Intestinal transplantation is a complex technical procedure that provides patients suffering from end-stage intestinal failure an opportunity to enjoy improved quality of life, nutrition and survival. Compared to other types of organ transplants, it is a relatively new advancement in the field of organ transplantation. Nevertheless, great advances have been made over the past few decades to the present era, including the use of ischemic preconditioning, gene therapy, and addition of pharmacological supplements to preservation solutions. However, despite these strides, intestinal transplantation is still a challenging endeavor due to several factors. Notable among them is ischemia-reperfusion injury (IRI), which results in loss of cellular integrity and mucosal barrier function. In addition, IRI causes graft failure, delayed graft function, and decreased graft and recipient survival. This has necessitated the search for novel therapeutic avenues and improved transplantation protocols to prevent or attenuate intestinal IRI. Among the many candidate agents that are being investigated to combat IRI and its associated complications, nitric oxide (NO). NO is an endogenously produced gaseous signaling molecule with several therapeutic properties. The purpose of this mini-review is to discuss IRI and its related complications in intestinal transplantation, and NO as an emerging pharmacological tool against this challenging pathological condition. i</p></div>","PeriodicalId":19357,"journal":{"name":"Nitric oxide : biology and chemistry","volume":"149 ","pages":"Pages 1-6"},"PeriodicalIF":3.9,"publicationDate":"2024-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141162025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chenguang Wei, Anni Vanhatalo, Matthew I. Black, Jamie R. Blackwell, Raghini Rajaram, Stefan Kadach, Andrew M. Jones
{"title":"Relationships between nitric oxide biomarkers and physiological outcomes following dietary nitrate supplementation","authors":"Chenguang Wei, Anni Vanhatalo, Matthew I. Black, Jamie R. Blackwell, Raghini Rajaram, Stefan Kadach, Andrew M. Jones","doi":"10.1016/j.niox.2024.04.010","DOIUrl":"10.1016/j.niox.2024.04.010","url":null,"abstract":"<div><p>Dietary nitrate (NO<sub>3</sub><sup>−</sup>) supplementation can increase nitric oxide (NO) bioavailability, reduce blood pressure (BP) and improve muscle contractile function in humans. Plasma nitrite concentration (plasma [NO<sub>2</sub><sup>−</sup>]) is the most oft-used biomarker of NO bioavailability. However, it is unclear which of several NO biomarkers (NO<sub>3</sub><sup>−</sup>, NO<sub>2</sub><sup>−</sup>, S-nitrosothiols (RSNOs)) in plasma, whole blood (WB), red blood cells (RBC) and skeletal muscle correlate with the physiological effects of acute and chronic dietary NO<sub>3</sub><sup>−</sup> supplementation. Using a randomized, double-blind, crossover design, 12 participants (9 males) consumed NO<sub>3</sub><sup>−</sup>-rich beetroot juice (BR) (∼12.8 mmol NO<sub>3</sub><sup>−</sup>) and NO<sub>3</sub><sup>−</sup>-depleted placebo beetroot juice (PL) acutely and then chronically (for two weeks). Biological samples were collected, resting BP was assessed, and 10 maximal voluntary isometric contractions of the knee extensors were performed at 2.5–3.5 h following supplement ingestion on day 1 and day 14. Diastolic BP was significantly lower in BR (−2 ± 3 mmHg, <em>P</em> = 0.03) compared to PL following acute supplementation, while the absolute rate of torque development (RTD) was significantly greater in BR at 0–30 ms (39 ± 57 N m s<sup>−1</sup>, <em>P</em> = 0.03) and 0–50 ms (79 ± 99 N m s<sup>−1</sup>, <em>P</em> = 0.02) compared to PL following two weeks supplementation. Greater WB [RSNOs] rather than plasma [NO<sub>2</sub><sup>−</sup>] was correlated with lower diastolic BP (<em>r</em> = −0.68, <em>P</em> = 0.02) in BR compared to PL following acute supplementation, while greater skeletal muscle [NO<sub>3</sub><sup>−</sup>] was correlated with greater RTD at 0–30 ms (<em>r</em> = 0.64<em>, P=</em>0.03) in BR compared to PL following chronic supplementation. We conclude that [RSNOs] in blood, and [NO<sub>3</sub><sup>−</sup>] in skeletal muscle, are relevant biomarkers of NO bioavailability which are related to the reduction of BP and the enhanced muscle contractile function following dietary NO<sub>3</sub><sup>−</sup> ingestion in humans.</p></div>","PeriodicalId":19357,"journal":{"name":"Nitric oxide : biology and chemistry","volume":"148 ","pages":"Pages 23-33"},"PeriodicalIF":3.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S108986032400065X/pdfft?md5=aef4e36cffba5496c4beadf4d7c9713d&pid=1-s2.0-S108986032400065X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140862977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katherine A. Kelly , Cristine L. Heaps , Guoyao Wu , Vinod Labhasetwar , Cynthia J. Meininger
{"title":"Nanoparticle-mediated delivery of tetrahydrobiopterin restores endothelial function in diabetic rats","authors":"Katherine A. Kelly , Cristine L. Heaps , Guoyao Wu , Vinod Labhasetwar , Cynthia J. Meininger","doi":"10.1016/j.niox.2024.04.009","DOIUrl":"https://doi.org/10.1016/j.niox.2024.04.009","url":null,"abstract":"<div><p>Endothelial dysfunction, underlying the vascular complications of diabetes and other cardiovascular disorders, may result from uncoupling of endothelial nitric oxide synthase (eNOS) activity due to decreased levels of tetrahydrobiopterin (BH4), a critical co-factor for eNOS. Some clinical trials attempting to deliver exogenous BH4 as a potential therapeutic strategy in vascular disease states have failed due to oxidation of BH4 in the circulation. We sought to develop a means of protecting BH4 from oxidation while delivering it to dysfunctional endothelial cells. Polymeric and solid lipid nanoparticles (NPs) loaded with BH4 were delivered by injection or oral gavage, respectively, to streptozotocin-induced diabetic rats. BH4 was measured in coronary endothelial cells and endothelium-dependent vascular reactivity was assessed in vascular rings. Lymphatic uptake of orally delivered lipid NPs was verified by sampling mesenteric lymph. BH4-loaded polymeric NPs maintained nitric oxide production by cultured endothelial cells under conditions of oxidative stress. BH4-loaded NPs, delivered via injection or ingestion, increased coronary endothelial BH4 concentration and improved endothelium-dependent vasorelaxation in diabetic rats. Pharmacodynamics assessment indicated peak concentration of solid lipid NPs in the systemic bloodstream 6 hours after ingestion, with disappearance noted by 48 hours. These studies support the feasibility of utilizing NPs to deliver BH4 to dysfunctional endothelial cells to increase nitric oxide bioavailability. BH4-loaded NPs could provide an innovative tool to restore redox balance in blood vessels and modulate eNOS-mediated vascular function to reverse or retard vascular disease in diabetes.</p></div>","PeriodicalId":19357,"journal":{"name":"Nitric oxide : biology and chemistry","volume":"148 ","pages":"Pages 13-22"},"PeriodicalIF":3.9,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1089860324000521/pdfft?md5=1538ec9258168d27a80e05ecb4b33592&pid=1-s2.0-S1089860324000521-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140650345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tarciso A. Sellani , Samanta L. Tomaz , Jéssica M. Gonçalves , Adriana Lima , Carolina C. de Amat Herbozo , Gabrielli N. Silva , Mônica Gambero , Ieda M. Longo-Maugéri , Karin A. Simon , Hugo P. Monteiro , Elaine G. Rodrigues
{"title":"Macrophages, IL-10, and nitric oxide increase, induced by hyperglycemic conditions, impact the development of murine melanoma B16F10-Nex2","authors":"Tarciso A. Sellani , Samanta L. Tomaz , Jéssica M. Gonçalves , Adriana Lima , Carolina C. de Amat Herbozo , Gabrielli N. Silva , Mônica Gambero , Ieda M. Longo-Maugéri , Karin A. Simon , Hugo P. Monteiro , Elaine G. Rodrigues","doi":"10.1016/j.niox.2024.04.007","DOIUrl":"https://doi.org/10.1016/j.niox.2024.04.007","url":null,"abstract":"<div><p>Epidemiological studies show a strong correlation between diabetes and the increased risk of developing different cancers, including melanoma. In the present study, we investigated the impact of a streptozotocin (STZ)-induced hyperglycemic environment on B16F10-Nex2 murine melanoma development. Hyperglycemic male C57Bl/6 mice showed increased subcutaneous tumor development, partially inhibited by metformin. Tumors showed increased infiltrating macrophages, and augmented IL-10 and nitric oxide (NO) concentrations. <em>In vivo</em> neutralization of IL-10, NO synthase inhibition, and depletion of macrophages reduced tumor development. STZ-treated TLR4 KO animals showed delayed tumor development; the transfer of hyperglycemic C57Bl/6 macrophages to TLR4 KO reversed this effect. Increased concentrations of IL-10 present in tumor homogenates of hyperglycemic mice induced a higher number of pre-angiogenic structures <em>in vitro</em>, and B16F10-Nex2 cells incubated with different glucose concentrations <em>in vitro</em> produced increased levels of IL-10. In summary, our findings show that a hyperglycemic environment stimulates murine melanoma B16F10-Nex2 primary tumor growth, and this effect is dependent on tumor cell stimulation, increased numbers of macrophages, and augmented IL-10 and NO concentrations. These findings show the involvement of tumor cells and other components of the tumor microenvironment in the development of subcutaneous melanoma under hyperglycemic conditions, defining novel targets for melanoma control in diabetic patients.</p></div>","PeriodicalId":19357,"journal":{"name":"Nitric oxide : biology and chemistry","volume":"148 ","pages":"Pages 1-12"},"PeriodicalIF":3.9,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140632822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tanveer A. Tabish , Jiamin Xu , Christopher K. Campbell , Manzar Abbas , William K. Myers , Pravin Didwal , Dario Carugo , Fang Xie , Mark J. Crabtree , Eleanor Stride , Craig A. Lygate
{"title":"pH-sensitive release of nitric oxide gas using peptide-graphene co-assembled hybrid nanosheets","authors":"Tanveer A. Tabish , Jiamin Xu , Christopher K. Campbell , Manzar Abbas , William K. Myers , Pravin Didwal , Dario Carugo , Fang Xie , Mark J. Crabtree , Eleanor Stride , Craig A. Lygate","doi":"10.1016/j.niox.2024.04.008","DOIUrl":"https://doi.org/10.1016/j.niox.2024.04.008","url":null,"abstract":"<div><p>Nitric oxide (NO) donating drugs such as organic nitrates have been used to treat cardiovascular diseases for more than a century. These donors primarily produce NO systemically. It is however sometimes desirable to control the amount, location, and time of NO delivery. We present the design of a novel pH-sensitive NO release system that is achieved by the synthesis of dipeptide diphenylalanine (FF) and graphene oxide (GO) co-assembled hybrid nanosheets (termed as FF@GO) through weak molecular interactions. These hybrid nanosheets were characterised by using X-ray diffraction, Raman spectroscopy, Fourier transform infrared spectroscopy, zeta potential measurements, X-ray photoelectron spectroscopy, scanning and transmission electron microscopies. The weak molecular interactions, which include electrostatic, hydrogen bonding and π-π stacking, are pH sensitive due to the presence of carboxylic acid and amine functionalities on GO and the dipeptide building blocks. Herein, we demonstrate that this formulation can be loaded with NO gas with the dipeptide acting as an arresting agent to inhibit NO burst release at neutral pH; however, at acidic pH it is capable of releasing NO at the rate of up to 0.6 μM per minute, comparable to the amount of NO produced by healthy endothelium. In conclusion, the innovative conjugation of dipeptide with graphene can store and release NO gas under physiologically relevant concentrations in a pH-responsive manner. pH responsive NO-releasing organic-inorganic nanohybrids may prove useful for the treatment of cardiovascular diseases and other pathologies.</p></div>","PeriodicalId":19357,"journal":{"name":"Nitric oxide : biology and chemistry","volume":"147 ","pages":"Pages 42-50"},"PeriodicalIF":3.9,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S108986032400051X/pdfft?md5=3dd8deb85683d1ce4afd8e1ac3e471e9&pid=1-s2.0-S108986032400051X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140557750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Naiara Cristina Bessas , Evelyn Christine de Souza Arantes , Natasha Marques Cassani , Uriel Enrique Aquino Ruiz , Igor Andrade Santos , Daniel Oliveira Silva Martins , Ana Laura Costa Oliveira , Giovanna André Antoniucci , Arthur Henrique Cavalcante de Oliveira , Gilson DeFreitas-Silva , Ana Carolina Gomes Jardim , Renata Galvão de Lima
{"title":"Influence of diimine bidentate ligand in the nitrosyl and nitro terpyridine ruthenium complex on the HSA/DNA interaction and antiviral activity","authors":"Naiara Cristina Bessas , Evelyn Christine de Souza Arantes , Natasha Marques Cassani , Uriel Enrique Aquino Ruiz , Igor Andrade Santos , Daniel Oliveira Silva Martins , Ana Laura Costa Oliveira , Giovanna André Antoniucci , Arthur Henrique Cavalcante de Oliveira , Gilson DeFreitas-Silva , Ana Carolina Gomes Jardim , Renata Galvão de Lima","doi":"10.1016/j.niox.2024.04.006","DOIUrl":"https://doi.org/10.1016/j.niox.2024.04.006","url":null,"abstract":"<div><p>Nitric oxide (NO) acts in different physiological processes, such as blood pressure control, antiparasitic activities, neurotransmission, and antitumor action. Among the exogenous NO donors, ruthenium nitrosyl/nitro complexes are potential candidates for prodrugs, due to their physicochemical properties, such as thermal and physiological pH stability. In this work, we proposed the synthesis and physical characterization of the new nitro terpyridine ruthenium (II) complexes of the type [Ru<sup>II</sup>(L)(NO<sub>2</sub>)(tpy)]PF<sub>6</sub> where tpy = 2,2':6′,2″-terpyridine; L = 3,4-diaminobenzoic acid (bdq) or <em>o</em>-phenylenediamine (bd) and evaluation of influence of diimine bidentate ligand NH.NHq-R (R = H or COOH) in the HSA/DNA interaction as well as antiviral activity. The interactions between HSA and new nitro complexes [Ru<sup>II</sup>(L)(NO<sub>2</sub>)(tpy)]<sup>+</sup> were evaluated. The <em>K</em><sub>a</sub> values for the HSA–[Ru<sup>II</sup>(bdq)(NO<sub>2</sub>)(tpy)]<sup>+</sup> is 10 times bigger than HSA–[Ru<sup>II</sup>(bd)(NO<sub>2</sub>)(tpy)]<sup>+</sup>. The sites of interaction between HSA and the complexes via synchronous fluorescence suppression indicate that the [Ru<sup>II</sup>(bdq)(NO<sub>2</sub>)(tpy)]<sup>+</sup> is found close to the Trp-241 residue, while the [Ru<sup>II</sup>(bd)(NO<sub>2</sub>)(tpy)]<sup>+</sup> complex is close to Tyr residues. The interaction with fish sperm <em>fs</em>-DNA using direct spectrophotometric titration (K<sub>b</sub>) and ethidium bromide replacement (K<sub>SV</sub> and K<sub>app</sub>) showed weak interaction in the system <em>fs</em>-DNA-[Ru<sup>II</sup>(bdq)(NO)(tpy)]<sup>+</sup>. Furthermore, <em>fs</em>-DNA–[Ru<sup>II</sup>(bd)(NO<sub>2</sub>)(tpy)]<sup>+</sup> and <em>fs</em>-DNA–[Ru<sup>II</sup>(bd)(NO)(tpy)]<sup>3+</sup> system showed higher intercalation constant. Circular dichroism spectra for <em>fs</em>-DNA–[Ru<sup>II</sup>(bd)(NO<sub>2</sub>)(tpy)]<sup>+</sup> and <em>fs</em>-DNA–[Ru<sup>II</sup>(bd)(NO)(tpy)]<sup>3+</sup>, suggest semi-intercalative accompanied by major groove binding interaction modes. The [Ru<sup>II</sup>(bd)(NO<sub>2</sub>)(tpy)]<sup>+</sup> and [Ru<sup>II</sup>(bd)(NO)(tpy)]<sup>3+</sup> inhibit replication of Zika and Chikungunya viruses based in the nitric oxide release under <em>S</em>-nitrosylation reaction with cysteine viral.</p></div>","PeriodicalId":19357,"journal":{"name":"Nitric oxide : biology and chemistry","volume":"147 ","pages":"Pages 26-41"},"PeriodicalIF":3.9,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140549907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nitric oxide regulation of fetal and newborn lung development and function","authors":"Jesse D. Roberts Jr.","doi":"10.1016/j.niox.2024.04.005","DOIUrl":"https://doi.org/10.1016/j.niox.2024.04.005","url":null,"abstract":"<div><p>In the developing lung, nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) signaling are essential in regulating lung formation and vascular tone. Animal studies have linked many anatomical and pathophysiological features of newborn lung disease to abnormalities in the NO/cGMP signaling system. They have demonstrated that driving this system with agonists and antagonists alleviates many of them. This research has spurred the rapid clinical development, testing, and application of several NO/cGMP-targeting therapies with the hope of treating and potentially preventing significant pediatric lung diseases. However, there are instances when the therapeutic effectiveness of these agents is limited. Studies indicate that injury-induced disruption of several critical components within the signaling system may hinder the promise of some of these therapies. Recent research has identified basic mechanisms that suppress NO/cGMP signaling in the injured newborn lung. They have also pinpointed biomarkers that offer insight into the activation of these pathogenic mechanisms and their influence on the NO/cGMP signaling system's integrity in vivo. Together, these will guide the development of new therapies to protect NO/cGMP signaling and safeguard newborn lung development and function. This review summarizes the important role of the NO/cGMP signaling system in regulating pulmonary development and function and our evolving understanding of how it is disrupted by newborn lung injury.</p></div>","PeriodicalId":19357,"journal":{"name":"Nitric oxide : biology and chemistry","volume":"147 ","pages":"Pages 13-25"},"PeriodicalIF":3.9,"publicationDate":"2024-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140545949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Timothy G. Gaulton , Yi Xin , Marcus Victor , Alice Nova , Maurizio Cereda
{"title":"Imaging the pulmonary vasculature in acute respiratory distress syndrome","authors":"Timothy G. Gaulton , Yi Xin , Marcus Victor , Alice Nova , Maurizio Cereda","doi":"10.1016/j.niox.2024.04.004","DOIUrl":"https://doi.org/10.1016/j.niox.2024.04.004","url":null,"abstract":"<div><p>Acute respiratory distress syndrome (ARDS) is characterized by a redistribution of regional lung perfusion that impairs gas exchange. While speculative, experimental evidence suggests that perfusion redistribution may contribute to regional inflammation and modify disease progression. Unfortunately, tools to visualize and quantify lung perfusion in patients with ARDS are lacking. This review explores recent advances in perfusion imaging techniques that aim to understand the pulmonary circulation in ARDS. Dynamic contrast-enhanced computed tomography captures first-pass kinetics of intravenously injected dye during continuous scan acquisitions. Different contrast characteristics and kinetic modeling have improved its topographic measurement of pulmonary perfusion with high spatial and temporal resolution. Dual-energy computed tomography can map the pulmonary blood volume of the whole lung with limited radiation exposure, enabling its application in clinical research. Electrical impedance tomography can obtain serial topographic assessments of perfusion at the bedside in response to treatments such as inhaled nitric oxide and prone position. Ongoing technological improvements and emerging techniques will enhance lung perfusion imaging and aid its incorporation into the care of patients with ARDS.</p></div>","PeriodicalId":19357,"journal":{"name":"Nitric oxide : biology and chemistry","volume":"147 ","pages":"Pages 6-12"},"PeriodicalIF":3.9,"publicationDate":"2024-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140542854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Adapting nitric oxide: A review of its foundation, uses in austere medical conditions, and emerging applications","authors":"Brian Strickland , N. Stuart Harris","doi":"10.1016/j.niox.2024.04.003","DOIUrl":"https://doi.org/10.1016/j.niox.2024.04.003","url":null,"abstract":"<div><p>Nitric oxide was first identified as a novel and effective treatment for persistent pulmonary hypertension of the newborn (PPHN), and has since been found to be efficacious in treating acute respiratory distress syndrome (ARDS) and pulmonary hypertension. Physicians and researchers have also found it shows promise in resource-constrained settings, both within and outside of the hospital, such as in high altitude pulmonary edema (HAPE) and COVID-19. The treatment has been well tolerated in these settings, and is both efficacious and versatile when studied across a variety of clinical environments. Advancements in inhaled nitric oxide continue, and the gas is worthy of investigation as physicians contend with new respiratory and cardiovascular illnesses, as well as unforeseen logistical challenges.</p></div>","PeriodicalId":19357,"journal":{"name":"Nitric oxide : biology and chemistry","volume":"146 ","pages":"Pages 58-63"},"PeriodicalIF":3.9,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140540179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shamima Akhtar , Komal Sagar , Aishwarya Singh , Milind P. Hote , Ambuj Roy , Alpana Sharma
{"title":"Inflammation-induced sialin mediates nitrate efflux in dysfunctional endothelium affecting NO bioavailability","authors":"Shamima Akhtar , Komal Sagar , Aishwarya Singh , Milind P. Hote , Ambuj Roy , Alpana Sharma","doi":"10.1016/j.niox.2024.04.002","DOIUrl":"https://doi.org/10.1016/j.niox.2024.04.002","url":null,"abstract":"<div><h3>Aim</h3><p>The mechanism of NO bioavailability in endothelial dysfunction, the trigger for atherogenesis is still unclear as exogenous nitrate therapy fails to alleviate endothelial dysfunction. Recently, sialin, a nitrate transporter, has been linked to affect tissue nitrate/nitrite levels. Hence, we investigated the role of sialin in NO bioavailability in endothelial dysfunction.</p></div><div><h3>Methods</h3><p>Serum-starved HUVECs were stimulated with either TNFα or AT-2 for 24 h either alone or in the presence of autophagy inducer or autophagy inhibitor alone. Nitric oxide, nitrite, and nitrate levels were measured in cell supernatant and cell lysate. Quantitative real-time PCR, Annexin V-PI, and monocyte adhesion assays were performed. Immunofluorescence staining for sialin, vWF, and LC3 was performed. STRING database was used to create protein interacting partners for sialin.</p></div><div><h3>Results</h3><p>Sialin is strongly expressed in activated EC <em>in vitro</em> and atherosclerotic plaque as well as tumor neo-vessel ECs. Sialin mediates nitrate ion efflux and is negatively regulated by autophagy via mTOR pathway. Blocking sialin enhances NO bioavailability, autophagy, cell survival, and eNOS expression while decreasing monocyte adhesion. PPI shows LGALS8 to directly interact with sialin and regulate autophagy, cell-cell adhesion, and apoptosis.</p></div><div><h3>Conclusion</h3><p>Sialin is a potential novel therapeutic target for treating endothelial dysfunction in atherosclerosis and cancer.</p></div>","PeriodicalId":19357,"journal":{"name":"Nitric oxide : biology and chemistry","volume":"146 ","pages":"Pages 37-47"},"PeriodicalIF":3.9,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140351385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}